dinutuximab beta · Medicine question

Why is concomitant use of intravenous immunoglobulins with dinutuximab beta not recommended?

Name: Why is concomitant use of intravenous immunoglobulins with dinutuximab beta not recommended?
Published: 2026-11-08T01:45:05.576Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Concomitant intravenous immunoglobulins are not recommended with dinutuximab beta because they may interfere with dinutuximab beta-dependent cellular cytotoxicity.

Sources for this answer

Qarziba (Dinutuximab beta)Recordati UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 13Document updated 25 November 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about dinutuximab beta